Price
No data yet.
Social Signal Score
Revenue
$0.00Company Profile
- CEO
- Jing Rong Jean Cui
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 63
- Beta
- 0.00
- Country
- US
Financials
BLSM has only 2 quarterly periods on file — the charts below show the full history available.
Net Income
$-21.01MEBITDA
$-21.98MFree Cash Flow
$-20.95MEPS (diluted)
$-0.72Shares Outstanding (diluted)
29.08M+0.0%Operating Expenses
$22.11MCash & Debt
$116.00MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0.00 | $-60.55M | $-2.08 |
| 2024 | $0.00 | $-30.70M | $-1.06 |
Valuation
BLSMhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
80Social Signal Score
Mentions (1)
- Newsglobenewswire.com·6h ago·Negative
…e in EGFR-mutant NSCLC, a setting where no oral targeted therapies are approved SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc. (Nasdaq: BLSM), a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and develop innovative small molecule medicines for the treatment of cancer, today announced that updated data from the ongoing Phase 1/2 SOLARA trial describing anti-tumor activity of BH-30643 in patients with secondary epi…
View source ↗
Insider trading
Open-market buys and sells by BLSM officers and directors.
No open-market trades in the recent filings. All 1 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
1 further Form 4 entry is share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.